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Background: Individual genotypes at specific loci can result in different patterns of DNA methylation. These
methylation quantitative trait loci (meQTLs) influence methylation across extended genomic regions and may
underlie direct SNP associations or gene-environment interactions. We hypothesized that the detection of meQTLs
varies with ancestral population, developmental stage, and tissue type. We explored this by analyzing seven
datasets that varied by ancestry (African American vs. Caucasian), developmental stage (neonate vs. adult), and
tissue type (blood vs. four regions of postmortem brain) with genome-wide DNA methylation and SNP data. We
tested for meQTLs by constructing linear regression models of methylation levels at each CpG site on SNP
genotypes within 50 kb under an additive model controlling for multiple tests.
Results: Most meQTLs mapped to intronic regions, although a limited number appeared to occur in synonymous
or nonsynonymous coding SNPs. We saw significant overlap of meQTLs between ancestral groups, developmental
stages, and tissue types, with the highest rates of overlap within the four brain regions. Compared with a random
group of SNPs with comparable frequencies, meQTLs were more likely to be 1) represented among the most
associated SNPs in the WTCCC bipolar disorder results and 2) located in microRNA binding sites.
Conclusions: These data give us insight into how SNPs impact gene regulation and support the notion that
peripheral blood may be a reliable correlate of physiological processes in other tissues.
Keywords: DNA methylation, meQTL, mQTL, Developmental stage, Ancestry, Race, Gene regulation, Inter-individual
variation, Biomarker, BrainBackground
DNA methylation patterns vary widely across the gen-
ome by developmental stage and by tissue type [1], mak-
ing study design a challenge when the most relevant
tissue is not accessible from living humans. This is par-
ticularly true for studies of neurologic or psychiatric
traits. Although the most relevant tissues, like brain,
may be obtained from non-human subjects, animal
models often fail to adequately reflect the range of
symptoms seen in humans. As a result, peripheral tissues* Correspondence: alicia.smith@emory.edu
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reproduction in any medium, provided the orare commonly used to identify biomarkers due to their
ready availability.
A recent report characterized methylation patterns ex-
tensively in DNA derived from brain and blood samples
taken from the same individuals [2]. The study con-
firmed that genome-wide DNA methylation is highly
tissue-specific; however, the authors also noted a striking
similarity between DNA methylation differences in the
blood and brain (cerebellum and cortex) from the same
individual, prompting the hypothesis that between-
individual DNA methylation differences may be medi-
ated by DNA sequence variation, which does not vary
across tissues. Nevertheless, the study had only a limited
number of subjects and was not designed to address this
hypothesis directly.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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vealed that DNA methylation at specific loci can be in-
fluenced by sequence variations, such that individual
genotypes at a given locus may result in different pat-
terns of DNA methylation due to allele-specific methyla-
tion. These sites are called methylation quantitative trait
loci (meQTLs) and can influence the methylation pat-
tern across an extended genomic region [3,8]. Numerous
studies have found meQTLs in blood leukocytes, buccal
cells, brain tissue, and lymphoblast cell lines [3-7],
though there is only modest overlap between the SNP-
CpG relationships identified in each study.
The ability to detect an meQTL is influenced by statistical
power, which may depend on SNP allele frequency and link-
age disequilibrium (LD) structure, which vary based on an-
cestry, or the variance of methylation at a specific CpG site,
which may differ across stages of development or tissue
type. These SNP-CpG relationships have wide-reaching bio-
logical relevance and likely contribute to inter-individual
variation in gene regulation. The relationship between se-
quence variants and DNA methylation patterns in different
sets of individuals may also provide insight into complex
traits in which a particular environmental exposure associ-
ates with a trait only if incurred at a particular developmen-
tal window. Delineating sets of potential regulatory SNPs
across different ancestries, developmental stages, and tissue
types will help us assess the extent to which meQTLs can
be used for large-scale studies of a wide range of human
traits. This study marks an initial step in that process.
Results
meQTL detection
We assessed genome-wide genotypes and DNA methyla-
tion in seven cohorts (described in Methods) 222,888 SNPs
and 20,093 CpG sites that passed quality control (including
a restriction of MAF > .05 for SNPs) in all seven cohorts
were eligible for analysis. We tested a total of 529,224
unique SNP-CpG combinations where the SNP was within
50 kb of the CpG site. Numerous meQTLs were identified
in each cohort after a conservative Holm adjustment for
multiple testing (Additional file 1). To make comparisons
between meQTL detection, we limited to only the SNP-
CpG combinations that were present in every cohort
(Table 1). On average, the distance between associated
SNPs and CpG sites was ~15 kb (Figure 1) and did not dif-
fer substantially between cohorts. In each of the cohorts,
the majority of meQTLs mapped to intronic regions (49.2-
50.1%), though a limited number appeared to occur in syn-
onymous (1.7-1.9%) or nonsynonymous coding (1.5-1.7%)
SNPs. There was substantial overlap between the set of
SNPs identified as meQTLs in this study and meQTLs
(86.6-90.1%) or eQTLs (1.6-5.2%) identified in previous re-
ports [8,10]. We used an empirical sampling strategy (de-
scribed in Methods) to examine whether this overlap wassignificant: in 10,000 randomly chosen sets of SNP with
similar MAF, we found 0 instances of overlap as great as
the overlap in the original data, indicating that the observed
overlap is significantly greater than expected by chance (p
< 1×10-4).
Comparison of meQTLs by cohort
Of the meQTLs identified in each cohort, 10.6-49.5%
were unique to that cohort. Note that the number of
meQTLs identified varied substantially across cohorts, in
part due to differences in power across cohorts. For ex-
ample, 2055 meQTLs were found in umbilical cord
blood from Caucasian neonates (CB B) compared to 629
in umbilical cord blood from African American neonates
(CB A). Although these two groups had the same sample
size, linkage disequilibrium between markers is substan-
tially lower in African Americans than in Caucasians
[11], so SNPs in CB A are less likely to tag untyped
meQTLs. Despite the between-cohort differences in
power, a number of SNP-CpG associations were com-
mon across cohorts. To determine whether the observed
overlap between any two cohorts was significantly differ-
ent from that expected by chance, we used Fisher’s exact
test as described in Methods. There was significant over-
lap in meQTL detection between CB A and CB B
(Table 1; overlap of 21.3-69.5%, depending on which
group was treated as the baseline). Further, comparisons
of meQTLs detected in African American samples at
birth (CB A) and adult peripheral blood (PB) had similar
agreement (44.1-50.7%). Finally, comparisons between
Caucasian blood samples (CB B) and brain tissues
(FCTX, TCTX, CRBLM, and PONS) also demonstrated
greater overlap in detected meQTLs than would be ex-
pected by chance (18.5-31.6%). However, the highest
proportions of overlap occurred between brain regions
(35.8-71.7%). There is 6.6-35.1% overlap between PB and
the four brain regions, even though the cohorts differ by
both ancestral group and tissue type. All of the overlap
between pairs of cohorts mentioned above was highly
significant (Fisher’s exact p < 1×10-308); however, a caveat
of this analysis is that the four brain regions were sam-
pled from the same set of individuals. To investigate
whether the higher levels of overlap between brain tis-
sues are due to the sampling of brain tissue from a com-
mon set of subjects, we also calculated overlap from
pairs of brain samples after randomly partitioning the
subjects into two non-overlapping groups. Additional file
2 shows that for each pairwise comparison, the overlap
between detected meQTLs is only slightly smaller in
cross-tissue comparisons when comparing tissue sam-
pled from non-overlapping groups (i.e., group A vs. B)
vs. sampled from the same group (A vs. A, or B. vs. B).
For A vs. B comparisons, we again observed a signifi-
cantly larger number of overlapping meQTLs than
Table 1 Number of meQTLs detected in each dataset and the number and percent overlapping between datasets, in
the form number (percent)
# of PB CB A CB B FCTX TCTX CRBLM PONS
Cohort meQTLs 724 629 2055 2853 3029 2802 2150
PB 724 - 319 (50.7) 366 (17.8) 254 (8.9) 234 (7.7) 185 (6.6) 203 (9.4)
CB A 629 319 (44.1) - 437 (21.3) 205 (7.2) 196 (6.5) 165 (5.9) 211 (9.8)
CB B 2055 366 (50.6) 437 (69.5) - 650 (22.8) 649 (21.4) 517 (18.5) 587 (27.3)
FCTX 2853 254 (35.1) 205 (32.6) 650 (31.6) - 2046 (67.6) 1078 (38.5) 1414 (65.8)
TCTX 3029 234 (33.3) 196 (31.2) 649 (31.6) 2046 (71.7) - 1091 (38.9) 1480 (68.9)
CRBLM 2802 185 (25.6) 165 (26.2) 517 (25.2) 1078 (37.8) 1091 (36.0) - 1004 (46.7)
PONS 2150 203 (28.0) 211 (33.6) 587 (28.6) 1414 (49.6) 1480 (48.9) 1004 (35.8) -
Bold numbers are the total meQTLs identified in each cohort and serve as the denominator for calculation of percentages.
Upper triangle: number (percent) of meQTLs identified in top dataset (column header) that were also identified in left-hand dataset (row header).
Lower triangle: number (percent) of meQTLs identified in left-hand dataset (row header) that were also identified in top dataset (column header).
Abbreviations: CB B cord blood B, TCTX temporal cortex, FCTX frontal cortex, PONS pons, CRBLM cerebellum, CB A cord blood A, and PB peripheral blood.
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comparisons) despite having much lower power in these
partitioned analyses, suggesting that the observed over-
lap between brain tissues is not an artifact caused by the
sampling of brain tissue from a common set of subjects.
To verify that the overlap observed in Table 1 is robust
to differences in linkage disequilibrium (LD) patterns
among SNPs, we also performed secondary analyses
where we examined only a set of roughly independent
SNPs. Although fewer meQTLs were detected overall





























Figure 1 Distribution (probability density function) of
associated (colored) and unassociated (black) SNP-CpG pairs by
absolute distance in each cohort. Plot indicates that while the
distance is roughly uniformly distributed between 0–50 kb for most
pairs of SNPs and CpGs compared (black), the distance tends to be
shorter (< 10 kb) for pairs where a meQTL was identified.
Abbreviations: CB B: cord blood B, TCTX: temporal cortex, FCTX:
frontal cortex, PONS: pons, CRBLM: cerebellum, CB A: cord blood A,
and PB: peripheral blood.similarly large proportions of overlap in meQTL detec-
tion across cohorts when working with this pruned set
of SNPs (Additional file 3). To verify that our observed
associations are robust to how methylation was modeled,
we re-performed select analyses where we modeled
methylation using M-values (the logit transform of β-
values [12]) rather than modeling β-values directly.
Resulting test statistics for β-values vs. M-values were
extremely similar; a representative example is shown in
Additional file 4.
To visually evaluate the similarities and differences be-
tween cohorts, a hierarchical clustering analysis was per-
formed on the t-statistics from the meQTL association
tests (Figure 2). Only the 7323 SNP-CpG combinations
that were Holm-significant in at least one cohort were
included in this analysis. The heatmap in Figure 2 shows
that many of the meQTLs were consistent across the
seven cohorts (top and bottom of heatmap), while others
varied considerably between tissues (middle of heatmap).
Among these SNP-CpG combinations, 34.5% had t-
statistics with the same sign (i.e., associations in the
same direction) for all seven cohorts, compared to the
1.67% expected by chance (computed as ∏ pi +∏ (1 − pi),
where pi represents the proportion of positive t-statistics
in cohort i and ranges from .456 to .493 in our seven co-
horts). Similarly, 62.0% of SNP-CpG combinations had
the same sign for at least six of the seven cohorts, com-
pared to 13.0% expected by chance. Although in many
cases the associations were non-significant, this pattern
is consistent with variable power to detect these
meQTLs across cohorts. The hierarchical clustering tree
in Figure 2 shows that the cohorts cluster primarily by
ancestral group, likely reflecting differential power due
to allele frequency differences between African Ameri-
can and Caucasian populations. The tree again demon-
strates that the pattern of meQTL direction and
significance is most similar between the different brain
Figure 2 Hierarchical clustering heatmap showing similarities of t-statistics of the meQTLs across all cohorts. Each row represents one
SNP-CpG site tested; only SNP-CpG combinations that were significant in at least one cohort are included here. Columns represent cohorts (labels
at bottom), and the hierarchical clustering tree shows relative similarity in test statistics between the tissues and cohorts. Color represents strength
and direction of association t-statistics (see color key). Cohort abbreviations from left to right: CB B: cord blood B, TCTX: temporal cortex, FCTX:
frontal cortex, PONS: pons, CRBLM: cerebellum, CB A: cord blood A, and PB: peripheral blood.
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are many similarities across tissue types. For example, in
the comparisons between cerebellum (CRBLM) and cord
blood (CB B), 77.2% showed test statistics in the same
direction, as opposed to the 50.2% expected by chance.
All of the above differences were highly significant ac-
cording to binomial tests (p < 10-200).
Sixty-seven SNP-CpG associations were identified as
Holm-significant in all cohorts, independent of ancestry,
age, or tissue type; these SNP-CpG pairs tended to be in or
near 11 genes, many of which are involved in common bio-
logical processes, such as cell cycle progression (Additional
file 5). For example, a SNP (rs10760117) approximately 35
base pairs upstream of the seventh exon of PSMD5 associ-
ates with multiple CpG sites (cg09419670 and cg21717724)in the PSMD5 promoter in all cohorts examined
(8.47×10-55 < p < 1.14×10-14; Figure 3 and Additional
file 6). Note that while a similar association between
genotype and methylation is observed in all tissues, the
range of methylation proportions varies considerably
across tissues.
Differences in meQTLs by tissue, developmental stage,
and ancestral group
Examining the differences between these patterns may
provide insight into SNP associations relevant to a specific
tissue (Figure 4A), developmental stage (Figure 4B), or
ancestral group (Figure 4C). Specifically, we found that
genetic variation in and near APOE (apolipoprotein E)






















































Figure 3 Identification of meQTLs in multiple tissues. rs10760117 associates with DNA methylation of cg21717724 in representative plots: CB
B (A) and FCTX (B). See Additional file 6 for the remaining cohorts and tissues.)
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not even nominally associated in CRBLM or PB (Figure 4A,
p > .05). Similarly, SNPs in or near APLNR (aka AGTRL1;
apelin receptor) associated with methylation of a probe
(cg26637069) in CB A (minimum p = 2.91×10-10), but not
in adult PB (Figure 4B). Finally, SNPs near CFTR (cystic fi-
brosis transmembrane conductance regulator) demon-
strated Holm-significant genotype-dependent methylation
patterns (cg25509184) in CB B (minimum p= 7.26×10-15)
but not CB A (all p > 1.21×10-4, Figure 4C). Interestingly,
this cannot be attributed to differences in the minor allele
frequencies between CB A (average MAF= 26.0%) and CB
B (average MAF = 25.2%).
GWAS enrichment
To compare our findings with earlier results demonstrat-
ing that meQTLs in cerebellum tissue were enriched in
GWAS results for complex traits [9], we investigated
whether our brain meQTLs were more likely to be repre-
sented among the top SNP associations from the WTCCC
bipolar disorder study (defined here as p < 0.001, to be
consistent with [9]). We found that the Holm-significant
meQTLs identified in PONS were enriched (empirical
p-value = .019) for SNP associations from the GWAS.
When we performed a similar analysis using a looser def-
inition of meQTLs (p < .001), we saw enrichment in FCTX
(p < .0001), TCTX (p = .048), and PONS (p = .005), though
not CRBLM, as observed in [9].
miRNA enrichment
The meQTLs identified in this study were more likely to
occur in miRNA binding sites (3.7-5.2%) than SNPs that
were not meQTLs (2.9-3.1%) in multiple cohorts: FCTX
(empirical p-value = .002), TCTX (p = .001), CRBLM
(p < 1×10-4), PONS (p = .014), PB (p = .001), and CB A(p = .015). For example, rs3814309 associates with the
proportion of DNA methylation at cg04987894 (GSTM5)
in the FCTX (p = 1.22×10-16), TCTX (p = 2.68×10-12),
CRBLM (p = 2.95×10-11), PONS (p = 9.88×10-14), CB A
(7.76×10-6), CB B (p = 3.40×10-4), and PB (p = 2.63×10-4).
Interestingly, rs3814309 also lies on a binding site for
hsa-miR-1237 in all brain tissues examined.
Discussion
This study compared meQTLs in seven cohorts of similar
size and coverage. Although the number of meQTLs iden-
tified varied, those detected were often specific to a single
cohort. Despite this, we saw a highly significant degree of
overlap between cohorts made up of subjects from differ-
ent developmental stages and ancestral groups, as well as
between samples obtained from different tissues. Explor-
ing the nature of the similarities and differences from this
study will give us insight into the use of meQTLs for the
interpretation of large-scale studies.
DNA methylation patterns vary substantially between
different tissues [2], but the sequence variants influencing
methylation patterns may be consistent across tissues, as
exemplified in Figure 2 and Table 1. This study uncovered
a correlation between meQTLs identified in umbilical
cord blood and those identified in several brain regions in
an independent set of adult samples. Some of these
meQTLs are located in genes with common functions in
the blood and brain. For example, in CB B and each of the
brain cohorts, we saw multiple meQTLs across a region of
up to 20.3-kb that associated with a CpG site near ATP-
binding cassette, sub-family C (ABCC4). This gene en-
codes a drug transporter that functions at the blood–brain
barrier [13]. Still other genes have functions that are
exclusive in the brain. For example, in CB B and each
of the brain cohorts, meQTLs associated with a CpG






























































Figure 4 Differences in meQTL detection between (A) tissue types; APOE, (B) developmental stage; APLNR, and (C) ancestry; CFTR. Each
plot displays meQTL associations for a single CpG site (labeled at bottom center of plot): the x-axis represents genomic position of SNPs, while
the y-axis represents the -log p-value of the association between the SNP and the CpG site. Cohort abbreviations: PB: peripheral blood, CB A: cord
blood A, CB B: cord blood B, CRBLM: cerebellum, TCTX: temporal cortex, FCTX: frontal cortex, and PONS: pons.
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(HTR6; Additional file 1), which is expressed on in
many brain regions and plays a role in cognition[14,15]. Recently, Lambe and colleagues characterized
HTR6 expression levels in postmortem tissue over time
[16]. HTR6 expression varies substantially over the
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at which one is more susceptible to psychiatric ill-
nesses. Thus, examination of genotype-dependent DNA
methylation of HTR6 in peripheral blood may yield new
information about the dynamic regulatory processes oc-
curring in the brain. In contrast, genetic variation in
and near APOE associates with methylation patterns of
a CpG site in the first intron of that gene in FCTX,
TCTX, and PONS, but not in CRBLM or PB. APOE is
linked to Alzheimer’s disease [17], and this study sug-
gests that there may be limited insight to be gained
from studies of APOE regulation that are not conducted
in specific brain regions.
When comparing meQTLs detected in the blood of
neonates (CB A) versus an adult population (PB), we
again noted substantial (44.1-50.7%) though not complete
overlap. This is not particularly surprising since DNA
methylation patterns differentiate by developmental stage
as well as by tissue type [1]. Thus, if a gene involved in
growth and development is less active in adulthood,
meQTLs could be less detectable in adults based on the
variability in DNA methylation levels of that gene. For ex-
ample, in this study, we found associations between sev-
eral SNPs and a CpG site in the promoter of the apelin
receptor (AGTRL1) that were observable in blood from
neonates but not adults. Apelin and its receptor help to
stimulate hematopoiesis in embryonic stem cells, and dys-
regulation of these genes is linked to numerous disorders
related to blood flow problems and hypertension [18-21].
Because fetal development is a period of extensive cellular
replication and growth, epigenetic changes may establish
long-term patterns among exposed individuals [22-24].
Extrapolating from this, genetic variation may be more in-
fluential during specific periods across the lifespan. In-
deed, a recent study of meQTLs suggests that, in some
cases, DNA methylation may be the mechanism by which
genetic and environmental risk factors contribute to age-
related phenotypes, including LDL, lung function, and
longevity [25].
The power to detect meQTLs may be influenced by
variations in allele frequencies and LD structure between
cohorts, meaning we would expect to see differences in
cohorts in which the length of expected LD blocks vary.
Consistent with this, there were 3.3 times more meQTLs
detected in the Caucasian cord blood cohort (CB B)
compared to the African American cord blood cohort
(CB A). We saw significant, albeit incomplete, overlap
between meQTLs identified in both cohorts. In fact,
14.0-45.1% were specific to either CB A or CB B. For ex-
ample, SNPs near CFTR (cystic fibrosis transmembrane
conductance regulator) associate with methylation of a
CpG site in the promoter region of CFTR in umbilical
cord blood samples from Caucasian but not African
American neonates. Genetic variants in CFTR causecystic fibrosis, a Mendelian condition that is more preva-
lent in Caucasians [26,27]. Methylation-associated SNPs
may be in LD with functional mutations that are more
common in Caucasians than in African Americans, but
the difference in genotype-dependent methylation patterns
cannot be attributed to differences in the minor allele fre-
quencies between the two cohorts. DNA methylation pat-
terns vary significantly by ancestry [28-30], prompting
several to suggest that epigenetic differences may contrib-
ute to the increased risk of African Americans for a variety
of health conditions [31-33]. Studies of epigenetic differ-
ences may provide insight into health disparities [34], and
meQTLs can help distinguish between genetic and epigen-
etic effects in such studies.
Because of their regulatory potential, identification of
meQTLs may also be useful to harness the power of
GWAS more efficiently [35]. The majority of meQTLs
from this study localized to intronic regions. Despite
this, we still saw significant enrichment of the meQTLs
from FCTX, TCTX, and PONS in a GWAS study of bi-
polar disorder (BPD) [36]. A recent study suggests that
the top associations from a GWAS of BPD are enriched
for meQTLs in a cerebellum dataset; when only the
SNPs that associated with DNA methylation patterns
were examined for association with BPD, associations
that met Bonferroni criteria were identified in multiple
cohorts [9]. In addition, the results of this study suggest
enrichment of miRNA binding sites among meQTLs, in-
dicating these SNPs may promote a more complex de-
gree of epigenetic regulation.
Though we attempted to present results from similarly
powered cohorts, this study has several limitations. We
would expect to identify more meQTLs if the cohorts
were larger or if DNA methylation were assessed more
densely. Due to study design and cohort availability,
between-ancestry comparisons were limited to neonates.
While DNA methylation was assessed in distinct tissues,
those tissues contain multiple cell types. Thus, PB in-
cluded the full range of leukocyte subpopulations, and
the brain regions contained both a variety of neuronal
phenotypes and glial cells. The corrections for multiple
comparisons were conservative, and we have every con-
fidence that the sets of meQTLs we identified are robust.
We would expect, however, to have greater power to de-
tect meQTLs in a study of homogenous cell types. In
addition, bisulfite conversion does not distinguish be-
tween methylcytosine and hydroxymethylcytosine, which
may be present in varying proportions in the seven co-
horts used for this study.
Conclusions
Our findings reveal similarities in genotype-dependent
DNA methylation across a diverse range of subject
characteristics and tissues. Though DNA methylation
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inter-individual variation in gene regulation remains
understudied. We need to further explore and characterize
such regions of the genome to facilitate population-based
studies of disease and for biomarker development. More
specifically, these data support the utility of studying per-
ipheral blood when the ideal tissue is unavailable and pro-
vide scope for interpreting those results.
Methods
Cohorts
Adult peripheral blood (PB) was assessed in African
American subjects recruited as part of a larger study in-
vestigating the influence of genetic and environmental fac-
tors on response to stressful life events in a predominantly
urban population of low socioeconomic status [37,38].
Umbilical cord blood data were obtained from previous
investigations in the CANDLE study, which assesses
developmental outcomes in a community cohort from
Shelby County, TN [39]. Because CANDLE includes
African Americans and Caucasians in roughly equal pro-
portions, the dataset was divided into two cohorts repre-
senting umbilical cord blood from African American
(CB A) and Caucasian (CB B) neonates. Finally, publically
available DNA methylation data were obtained for post-
mortem samples of the frontal cortex (FCTX), temporal
cortex (TCTX), cerebellum (CRBLM), and pons (PONS)
of a single group of neurologically normal adult Caucasian
subjects [8]. The characteristics of the seven cohorts ex-
amined in this study are summarized in Table 2. The insti-
tutional review boards for Emory University and Grady
Memorial Hospital (for PB) as well as the University of
Tennessee Health Science Center (for CB A and CB B)
approved their respective studies. For the FCTX, TCTX,
CRBLM, and PONS cohorts, individual-level data were
obtained in accordance with an active Data Use Certifica-
tion (to A.K.S.) for GEO Accession Number GSE15745
and dbGAP Study Accession phs000249.v1.p1.Table 2 Characteristics of the study cohorts








42.5 ± 14.0 57.7
Cord blood A CB A 87 African
American
0.0 ± 0.0 55.2
Cord blood B CB B 87 Caucasian 0.0 ± 0.0 44.8
Frontal
cortex
FCTX 111 Caucasian 47.6 ± 23.8 67.6
Temporal
cortex
TCTX 125 Caucasian 48.2 ± 24.5 66.9
Cerebellum CRBLM 105 Caucasian 46.6 ± 23.0 71
Pons PONS 106 Caucasian 46.5 ± 24.0 69.6DNA methylation data
The methylation datasets for this analysis have been de-
scribed previously [8,30,40]. For each cohort, DNA
methylation was first assessed at 27,578 CpG sites using
the HumanMethylation27 BeadChip (Illumina). Samples
with probe detection call rates < 90% were excluded, as
were those with an average intensity value of either <
50% of the experiment-wide sample mean or < 2,000 ar-
bitrary units. Data points with detection p-values > 0.001
were set to missing. Estimated DNA methylation pro-
portions or β-values were then computed for each CpG
site and sampled as the ratio of methylated signal to
total (methylated + unmethylated) signal. Principal com-
ponents analysis (PCA) of the β-values was then used to
identify and eliminate 9 outliers from PONS, 21 from
FCTX, and 6 from CRBLM, where outliers were deter-
mined as samples that fell more than 2.5 standard devia-
tions away from the origin in plots of the first two
principal components (Additional file 7). Additional file
7 also indicates batch effects in the brain samples, so we
adjusted for these in our analysis as described below. No
other cohort had evidence of outliers, and samples were
hybridized in a single batch for each of the other co-
horts. CpG sites with 1000 Genomes Project (Pilot 1
Data Release 2010_03) variants physically contained
within the Illumina probe were excluded from all ana-
lyses, since CpG-SNP associations involving sites with
variants in the probe are likely to be technical artifacts.
After this step, 20,093 CpG sites passing QC in all co-
horts remained eligible for analysis.
Genotyping data
Genotyping for each cohort has been described previ-
ously [8,30]. Genotyping was performed using multiple
platforms: Illumina Omni-Quad 1 M, Omni-Express
BeadChips (PB), HumanHap550 (FCTX, TCTX, CRBLM,
PONS), and Affymetrix Genome-Wide Human SNP Array
5.0 and 6.0 (CB A and CB B). PLINK was used to perform
quality control analyses such that, for all datasets,
SNPs that had a call rate < 95%, a minor allele frequency
(MAF) < .05, or significant deviation from Hardy-Weinberg
proportions (p < .00001) were excluded, as were samples
with > 5% missing data. So that annotation information was
consistent between all datasets, the positional information
for all the genotype datasets was converted to build 36 of
the Human genome using the UCSC liftover tool when ne-
cessary [41]. All allelic designations are oriented to the for-
ward strand.
MaCH 1.0 [42] was used to impute missing genotypes
for SNPs that were not common to each array. Caucasian
datasets were imputed using the HapMap CEU +TSI
phase 3 reference samples, and the African American
datasets were imputed using unrelated individuals from
HapMap ASW, CEU, LWK, MKK, TSI, and YRI Phase 3
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between imputed and true genotypes and those with pos-
terior probabilities < .9 for the most likely genotype were
excluded from subsequent analysis. After imputation,
222,888 SNPs with MAF > .05 passed quality control
based on genotyping or imputation in all cohorts and were
eligible for analysis.
Statistical analysis
All statistical analyses were conducted in R. The rela-
tionship between the β-value or proportion of methyla-
tion at each CpG site and each SNP within 50 kb of that
site was examined via linear regression, where β-values
were modeled as a linear function of the number of ref-
erence alleles (0, 1, or 2). As appropriate, we included
covariates to account for Affymetrix array 5.0 vs. 6.0 (CB
A and CB B), or hybridization batch (FCTX, TCTX,
CRBLM, PONS; other cohorts were hybridized in a sin-
gle batch). To eliminate the possibility of inflated test
statistics due to the lack of power at particular sites, ana-
lysis was restricted to SNP-CpG combinations with
complete data for 32 or more subjects in each cohort (i.e.,
residual degrees of freedom ≥ 30). A Holm (step-down
Bonferroni) correction [43] was applied to adjust for the
total number of tests performed in each dataset; this type
of approach will maintain the experiment-wide type I
error rate at 5% for independent tests and will be even
more conservative for the correlated tests performed here
[44]. Gene ontology (GO) terms for biological processes
were assigned using GeneCodis 2.0 [45,46]. We used
SNAP to map the location of each meQTL relative to its
location within a gene [47].
To test whether the overlap of meQTLs identified be-
tween each pair of cohorts was significantly greater than
that expected by chance, we used Fisher’s exact test to
test for independence between meQTL status in one co-
hort vs. meQTL status in another cohort. To test for en-
richment in other datasets, we used an empirical
sampling strategy. We first used this strategy to test for
significant overlap between the set of meQTLs identified
in each cohort and the set of variants listed in the Well-
come Trust GWAS for bipolar disorder [36]. To gener-
ate an empirical p-value for the enrichment test, for
each cohort we randomly sampled sets of X SNPs from
the full set of SNPs analyzed, where X is the number of
SNPs identified as significant meQTLs in that cohort.
To ensure that the distribution of MAF in the randomly
drawn datasets was similar to the original, SNPs in each
cohort were binned by MAF intervals of .025. For each
random sample we then sampled the same number of
SNPs from each bin as in the original set of significant
meQTLs. For each random set, we computed the num-
ber of overlapping SNPs as the number of GWAS SNPs
included in the random set of X SNPs, and comparedthis number to the number of overlapping SNPs in the
original analysis. The empirical p-value was then the
proportion of random SNP sets demonstrating at least
as much overlap with the GWAS SNPs as observed in
the original analysis.
We also used the strategy described above to compare
enrichment of meQTLs from this study to published
meQTL and eQTL results. For blood cohorts (PB, CB A,
and CB B), we compared to eQTLs detected by Stranger
and colleagues [10], and for brain cohorts (FCTX, TCTX,
CRBLM, and PONS), we compared to meQTLs and
eQTLs detected by Gibbs and colleagues [8]. Each enrich-
ment test was conducted with 10,000 randomly sampled
SNP sets, similar to those described above.
To identify meQTLs that could influence miRNA bind-
ing, we examined the list of SNPs in predicted miRNA-
mRNA binding sites from the MirSNP database (http://
cmbi.bjmu.edu.cn/mirsnp). Similarly, we tested for enrich-
ment of the miRNA SNPs among the set of significant
meQTLs and generated an empirical p-value using 1000
randomly sampled sets of SNPs for each cohort.
For secondary analyses involving an independent set
of SNPs, we used PLINK to prune the genotype data in
windows of 50 bp (base pairs), removing one SNP from
each pair of SNPs with r2 > 0.05. We then performed se-
lect analyses on this reduced set of roughly independent
SNPs (summarized in Additional file 3).
Additional material
The additional material contains three figures and four
tables that provide supporting information for specific
points in the paper.Additional files
Additional file 1: Table S1. meQTLs detected in each cohort.
Additional file 2: Table S2. Number of meQTLs detected in each
cohort and overlap between non-redundant samples. Table S3. Number
of meQTLs detected and overlap between independent SNPs. Table S4.
Gene ontology (GO) terms for meQTLs identified in all cohorts.
Additional file 3: Figure S1. Identification of meQTLs in multiple
tissues. rs10760117 associates with DNA methylation of cg21717724 in CB
A (A), CB B (B), PB (C), FCTX (D), TCTX (E), CRBLM (F), and PONS (G).
Figure S2. Principal component analysis used to identify and remove
outliers from each cohort. Figure S3. T-statistics for Holm-significant
CpG-SNP associations are extremely similar in analyses of β-values (Y-axis)
vs. M-values (X-axis).
Additional file 4: T-statistics for Holm-significant CpG-SNP
associations are extremely similar in analyses of β-values (Y-axis) vs.
M-values (X-axis).
Additional file 5: Gene Ontology (GO) terms for mQTLs identified in
all cohorts.
Additional file 6: Identification of meQTLs in multiple tissues.
rs10760117 associates with DNA methylation of cg21717724 in CB A (A),
CB B (B), PB (C), FCTX (D), TCTX (E), CRBLM (F), and PONS (G).
Additional file 7: Principal component analysis used to identify and
remove outliers from each cohort.
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